P&G on market research
This article was originally published in The Rose Sheet
Executive Summary
About 50% of U.S. retail sales in categories in which Procter & Gamble competes are not tracked by Information Resources, Inc. and A.C. Nielsen, CFO Clayton Daley points out during Oct. 29 review of Q1 results. "Our estimates indicate U.S. consumer categories in which we operate are growing about four percentage points faster than the data provided by the main U.S. share data services," he says, adding growth rate differences in P&G businesses have "consistently been even higher." Referring to Wal-Mart's 2001 decision to withhold sales data from research firms, he explains underestimates reflect the fact that unmonitored retail channels, which include club and convenience stores, are growing faster than the food, drug and select mass outlets that are tracked. To compensate, P&G says it is working with manufacturers and research firms to establish "all-outlet reporting capability" for market measurement...
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.